The Misuse of Drugs (Amendment) (England, Wales and Scotland) (Revocation) Regulations 2012

Statutory Instruments

2012 No. 385

Dangerous Drugs, England And Wales

Dangerous Drugs, Scotland

The Misuse of Drugs (Amendment) (England, Wales and Scotland) (Revocation) Regulations 2012

Made

15th February 2012

Laid before Parliament

17th February 2012

Coming into force

12th March 2012

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971(1).

In accordance with section 31(3) of that Act the Secretary of State has consulted with the Advisory Council on the Misuse of Drugs.

Citation, commencement and extent

1.—(1) These Regulations may be cited as the Misuse of Drugs (Amendment) (England, Wales and Scotland) (Revocation) Regulations 2012 and shall come into force on 12th March 2012.

(2) These Regulations extend to England, Wales and Scotland.

Revocation of the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012

2.  The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012(2) are revoked.

Lord Henley

Minister of State

Home Office

15th February 2012

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations, which come into force on 12th March 2012, revoke the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012. The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2012, which were made on 4th February 2012 and if not revoked by these Regulations would have come into force on 28th March 2012, would have amended the Misuse of Drugs Regulations 2001 (the “2001 Regulations”) by adding: desoxypipradrol and other pipradrol‑related compounds to Schedule 1 to the 2001 Regulations; 7‑bromo‑5‑(2‑chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (commonly known as phenazepam), and any ester or ether of pipradrol, or any stereoisomeric form or salt or preparation or other product of such an ester or ether, to Schedule 3 to the 2001 Regulations; and 7-Hydroxy-dehydroepiandrosterone and 7‑Keto‑dehydroepiandrosterone to Schedule 4 to the 2001 Regulations. The schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug.

(1)

1971 c. 38. Section 22 has been amended by section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979 (c. 2).

(2)

S.I. 2012/277, which was not published.